Synopsys (SNPS) Stock Forecast & Price Target

Q: What analysts cover Synopsys?

Synopsys has been rated by research analysts at Benchmark , KeyCorp , Mizuho , Morgan Stanley , Needham & Company LLC , Piper Sandler , Robert W. Baird , Rosenblatt Securities , UBS Group , Weiss Ratings , Wells Fargo & Company , and Zacks Research in the past 90 days.

$393.84 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Compare

Synopsys - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
1

Hold
5

Buy
12

Based on 18 Wall Street analysts who have issued ratings for Synopsys in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 1 has given a sell rating, 5 have given a hold rating, and 12 have given a buy rating for SNPS.

Consensus Price Target

$561.28
42.51% Upside

According to the 18 analysts' twelve-month price targets for Synopsys, the average price target is $561.28. The highest price target for SNPS is $650.00, while the lowest price target for SNPS is $450.00. The average price target represents a forecasted upside of 42.51% from the current price of $393.84.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for SNPS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Synopsys and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNPS Analyst Ratings Over Time

Type	Current Forecast 9/7/25 to 9/7/26	1 Month Ago 8/8/25 to 8/8/26	3 Months Ago 6/9/25 to 6/9/26	1 Year Ago 9/7/24 to 9/7/25
Strong Buy	0 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	10 Buy rating(s)	9 Buy rating(s)	12 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	7 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$561.28	$570.06	$563.81	$638.21
Forecasted Upside	42.51% Upside	37.04% Upside	21.18% Upside	6.70% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Hold	Moderate Buy

SNPS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SNPS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Synopsys Stock vs. The Competition

Type	Synopsys	Technology Companies	Broader Market
Consensus Rating Score	2.61	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	42.51% Upside	411.75% Upside	14.03% Upside
News Sentiment Rating	Positive News See Recent SNPS News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/27/2026	Weiss Ratings 5 of 5 stars		Upgrade	Hold (C-) ➝ Hold (C)
8/27/2026	UBS Group 4 of 5 stars		Set Target		$570.00	+24.96%
8/27/2026	Mizuho 3 of 5 stars	Siti Panigrahi 2 of 5 stars	Lower Target	Outperform	$600.00 ➝ $550.00	+23.20%
8/27/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$558.00 ➝ $560.00	+36.59%
8/27/2026	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Mobley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$570.00	+39.02%
8/27/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$580.00	+41.46%
8/25/2026	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$575.00	+45.75%
8/21/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
8/19/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lee Simpson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$525.00 ➝ $500.00	+23.98%
8/19/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
Get the Latest News and Ratings for SNPS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Synopsys and its competitors with MarketBeat's FREE daily newsletter.
8/11/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$535.00 ➝ $450.00	+9.31%
6/23/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$450.00 ➝ $550.00	+18.39%
5/28/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$550.00 ➝ $600.00	+20.00%
5/28/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelsey Chia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$600.00 ➝ $610.00	+27.80%
5/28/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew DeGasperi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Underperform	$425.00 ➝ $450.00	-6.27%
5/28/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$515.00 ➝ $600.00	+14.09%
5/27/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$633.00	+18.42%
2/25/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$600.00	+33.58%
2/20/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$455.00	+2.54%
12/11/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harlan Sur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $650.00	+37.51%
1/13/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lachlan Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$600.00	+21.82%
11/11/2024	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Mobley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$675.00	+21.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:31 PM ET.

Should I Buy Synopsys Stock? SNPS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 3, 2026. Please send any questions or comments about these Synopsys pros and cons to contact@marketbeat.com.

Synopsys
Bull Case

Here are some ways that investors could benefit from investing in Synopsys, Inc.:

Synopsys, Inc. recently reported strong financial performance for the quarter ended August 26, 2026, with revenue of $2.48 billion, which exceeded the analyst consensus estimate of $2.44 billion and represented a 42.4% year-over-year increase, demonstrating robust demand for its electronic design automation software and semiconductor intellectual property.
The company's adjusted earnings per share of $3.91 for the most recent quarter beat the consensus estimate of $3.67 by $0.24, indicating that Synopsys, Inc. is effectively managing its costs and generating higher profits than expected, which supports its valuation and potential for future earnings growth.
Wall Street analysts maintain a "Moderate Buy" consensus rating with a price target of $561.28, which suggests approximately 25% potential upside from the current stock price of $416.31, reflecting institutional confidence in the company's long-term trajectory and market position.
Synopsys, Inc. has raised its full-year 2026 earnings per share guidance to a range of $15.040 to $15.100, significantly above the previous consensus estimate of $13.960, signaling management's strong confidence in the company's ability to sustain high growth rates throughout the fiscal year.
The company's current stock price of $416.31 is below its 52-week high of $615.79, presenting a potential entry point for investors who believe the recent pullback is temporary and that the stock will recover as the semiconductor sector stabilizes and AI-related chip design demand continues to expand.

Synopsys
Bear Case

Investors should be bearish about investing in Synopsys, Inc. for these reasons:

Synopsys, Inc. trades at a high price-to-earnings ratio of 73.55, which makes the stock sensitive to rising interest rates and global bond yields, as evidenced by recent semiconductor sector declines when yields increased, potentially leading to further valuation compression.
Executive Chair Aart de Geus sold a combined 49,641 shares for roughly $21.4 million across transactions on August 31 and September 1, 2026, reducing his holdings by about 17%, which may signal insider caution or a desire to diversify holdings despite the sales being made under a pre-arranged trading plan.
The stock is currently trading below its 200-day moving average of $439.94, indicating a potential medium-term downtrend, and the recent 5.4% drop on insider selling suggests that market sentiment may be fragile and prone to negative reactions to any perceived weakness.
Some analysts, such as Zacks Research, have downgraded Synopsys, Inc. from a "strong-buy" to a "hold" rating, and Wells Fargo decreased its target price from $535.00 to $450.00, reflecting concerns about the company's high valuation relative to its growth prospects and potential competitive pressures.
Synopsys, Inc. faces competitive threats from companies like Marvell Technology, which is positioning itself to offer custom silicon solutions that could potentially reduce the need for traditional EDA tools, posing a long-term risk to Synopsys's market share and revenue growth in the AI chip design space.

SNPS Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Synopsys is $561.28, with a high forecast of $650.00 and a low forecast of $450.00.

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SNPS shares.

According to analysts, Synopsys's stock has a predicted upside of 42.51% based on their 12-month stock forecasts.

Over the previous 90 days, Synopsys's stock had 5 upgrades and 1 downgrade by analysts.

Synopsys has been rated by research analysts at Benchmark, KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Robert W. Baird, Rosenblatt Securities, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Synopsys more than other "technology" companies. The consensus rating for Synopsys is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how SNPS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Synopsys Recommendations

MarketBeat monitors more than a dozen sources for Synopsys analyst ratings, with the most recent rating issued on 8/27/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synopsys (SNPS) Stock Forecast & Price Target